Login to Your Account

Pharma: Other News To Note

Tuesday, July 30, 2013
Pfizer Inc., of New York, said it will separate its commercial operations into three business segments in January 2014. One will include inflammation and immunology, CV/metabolic diseases, neuroscience and pain, rare diseases and women's/men's health. Another will encompass vaccines, oncology and consumer health care.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription